logo
Plus   Neg
Share
Email

Seattle Genetics Issues Outlook

Seattle Genetics, Inc. (SGEN) said, for fiscal 2020, the company projects: ADCETRIS net product sales of $675 million to $700 million; and collaboration and license agreement revenues of $30 million to $50 million.

Fourth-quarter net income per share was $0.14, compared to a net loss of $0.75 per share, a year ago. Fourth-quarter revenues increased to $289.8 million from $174.5 million, a year ago. ADCETRIS net sales in the U.S. and Canada were $166.2 million, a 26 percent increase over net sales of $132.1 million, a year ago. Royalty revenues were $72.3 million, compared to $24.6 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apotex Corp. recalled all lots of type 2 diabetes medication Metformin hydrochloride in the form of oral film-coated tablets for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Groupe Renault plans to cut about 14,600 jobs across the world and lower its production capacity. The plan includes almost 4,600 jobs reduction in France, through voluntary retirement and retraining. Amazon said it will convert 125,000 of the 175,000 temporary workers it hired in March amid the coronavirus pandemic, to permanent full-time employees in June. The e-commerce giant had hired the temporary employees in March to meet strong consumer demand amid the lockdown. The job openings were in Amazon's fulfillment centers and its delivery network.
Follow RTT